Background: Herpes Simplex Virus (HSV) is the most common cause of acute sporadic focal encephalitis. Early Diagnosis is, therefore, crucial for predicting outcome. Improved laboratory technology and improved neuroimaging accessibility have enhanced our ability to diagnose this condition.
INTRODUCTION
Herpes simplex encephalitis (HSE) is a devastating central nervous system (CNS) infection with an estimated incidence of about 1 in 250,000 to 500,000 people per year and a third of cases occurring in children [1] . The mortality rate of untreated HSE in 70% in adults, and 23% of patients *Address correspondence to this author at the Department of Pediatrics, Division of Pediatric Neurology, College of Medicine, P.O. Box 2925, King Saud University, Riyadh 11461, Saudi Arabia; E-mail: mustafa_salih05@yahoo.com are able to return back to normal function [2] . A dramatic improvement of the survival rate and prognosis occurs if treatment is initiated very early after the onset of the disease [2] [3] [4] . Early diagnosis is, therefore, crucial for predicting the outcome [3] .
Detection of herpes simplex virus (HSV) in the cerebrospinal fluid (CSF) through polymerase chain reaction (PCR) is the diagnostic modality of choice for HSE [5] . However, negative results for PCR are reported in both adults [6] and children [3, [7] [8] [9] [10] [11] [12] . Therefore, recognition of imaging patterns of HSE is imperative [13] . Magnetic resonance imaging (MRI) reveals a disease in T1 signal and increased T2 signal in the medial temporal lobes and insulae, and in the orbital frontal lobes with abnormalities appearing earlier and more frequently than with brain computed tomography (CT) of the brain [14] . Recently, diffusionweighted imaging (DWI) was found to play a major role as a first and early diagnostic step [15] , especially within the first 72 hours of infection when CSF might be negative for HSV DNA using PCR technique [16] .
Other diagnostic studies for patients with presumed HSE include electroencephalography (EEG) which reveals focal abnormalities in about 80% of cases [17] . In some patients, widespread periodic lateralized epileptiform discharges (PLEDs) are seen [18] . Focal unilateral hyperperfusion, as visualized by single photon emission computed tomography (SPECT) brain scans, has also been proposed as a sensitive indicator of severe inflammation of the brain tissue in HSE [19] . It can also help in differentiating HSV infection from other ischemic, tumoral or demyelinating processes [20] .
The present study describes the clinical, laboratory, electroencephalographic and diagnostic imaging studies; and outcome in a cohort of 18 children with HSE seen at our institution over a period of 13 years. It also details the clinical and diagnostic features of 3 patients who relapsed.
PATIENTS AND METHODS
The study included children with suspected HSE, who were evaluated at the Division of Paediatric Neurology (DPN), or were inpatients in the paediatric wards at King Khalid University Hospital (KKUH), Riyadh, Saudi Arabia. As stipulated in its design, the study covered 13 years and had 2 components as follows:
Retrospective Study: This included 12 patients. All the case records of children who were evaluated at the DPN or admitted to KKUH with clinical features suggestive of HSE during the period June 1993 to May 2001 (8 years) were reviewed. The diagnosis of HSE was considered to be accepted when supported by the clinical and other ancillary findings. The latter included biological (CSF analyses, including HSV PCR in some cases), radiological (CT and/or MRI), electrophysiological (EEG) and nuclear (SPECT) investigations. Relevant information about each child was retrieved. This included age at onset of HSE, sex, clinical symptoms and signs, laboratory findings at presentation, EEG results, CNS imaging studies, hospital course, treatments and outcome. The time delay between the onset of symptoms and the date of admission, diagnosis and initiation of treatment as well as the dose and duration of acyclovir therapy were recorded.
Prospective Study: This included 6 patients seen between June 2001 and May 2006 (5 years). This group of patients were subjected to detailed history taking and thorough clinical examination, CSF, HSV DNA PCR, EEG studies, neuroimaging including either cranial CT scan, MRI or both and SPECT brain studies. Patients were treated with acyclovir for 21 days and were followed strictly for outcome.
The outcome of the disease was defined according to the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group [21] as follows: (1) Normal; (2) Mild sequelae (with minor neuropsychological deficits); (3) Moderate sequelae (with limitations to motor, speech, memory or seizure disorders) and (4) Severe sequelae (requirements for supporting care or death). Patients with normal and mild sequelae were classified as having good outcome and those with moderate and severe sequelae as having poor outcome. 
Methods

Statistical Analysis:
The Stat Pac Gold Statistical Analysis Package was used for data management. Fisher's exact test was used for comparison of data among the different groups. A probability value of < 0.05 was considered to be significant.
RESULTS
During the combined study period of 13 years, 18 Saudi patients with confirmed diagnosis of HSE were evaluated. They consisted of 9 males and 9 females, including two female siblings. Patients were aged from 3 months to 10 years with mean age of (3.2 y ± 2.9 y) and median 2 years. Among these, 5 patients (28%) were aged 3-12 months, 9 (50%) were 1 to 4 years of age and 4 patients (22%) were aged 5-10 years. Three out of the 18 patients got relapse of herpetic encephalitis later on during the study period at a mean age of (4.6y ± 3y) and median of 6 years. All 18 patients presented with fever ( Table 1) . Irritability (in 50%) and drowsiness (in 33%) were remarkable symptoms in all age groups, while headache mainly manifested in patients > 4 years (100%). Thirteen (72%) patients presented with focal seizures, 7 (39%) with hemiparesis, one (5.5%) patient presented with aphasia and another one (5.5%) with squint.
During the study period, 21 CSF samples were drawn from the patients within the first 5 days of illness. Analysis of CSF showed elevated white blood cell (WBC) count (> 10 x 10 6 L) in 13 (62%), red blood cells (RBCs) count > 10x10 6 L in 17 (81%) and raised proteins (> 0.59 g/l) in 11 (52%) samples. Examination for HSV by PCR in 12 (57%) of these 21 CSF specimens revealed positive results in 6 (50%). A statistical analysis revealed no significant associated between positive results of PCR and either the presence in the CSF of elevated WBC count (> 10 x 10 6 /L), RBCs (10 x 10 6 /L) or proteins (> 0.59 g/L). Repeated lumbar puncture was done for 5 patients during their course of their illness, and PCR was performed in 3 of them revealing a positive result in one patient on day 8 after onset of symptoms. The first CSF sample of this child, taken on day 3 of his illness, was negative for HSV by PCR.
Serological testing for HSV was done for 11 (61%) patients during the acute stage (within the first 5 days of illness). No serological tests were attempted at convalescence. Both anti-HSV IgG and IgM antibodies were positive in 3 (27%) of the 11 acute sera, whereas a fourth sample was positive for anti-HSV IgG antibodies only. Simultaneous CSF analysis for HSV PCR was done within the first 5 days of illness in 6 of these 11 patients and it revealed positive results in 2 (33%). There was no statistically significant association between positive PCR results for HSV in CSF and detection of anti-HSV IgM antibodies in acute sera.
Serial cranial CT scans revealed unilateral or bilateral hypodensity in the temporal lobes with, or without, involvement of other areas (frontal, parietal or occipital) in 8 (57%) of 14 patients. In 2 (14%) patients the abnormalities were confined to either frontal or occipitopariental lobes. Out of these 10 patients, the initial CT scan, done on days 1-8 from onset of symptoms, was normal in 5 (50%). Hyperdense lesions of hemorrhage were observed in 6 (60%) patients. Follow-up CT brain scan in the chronic stage of the disease, done for 3 patients, revealed encephalomalacia and brain atrophy.
On MRI, done during the acute stage, hyperintense signal (on T2-weighted images) and/or restricted diffusion abnormalities (on diffusion-weighted images) were seen in 10 (91%) of 11 patients. These corresponded to oedematous changes in the temporal lobes in 8 (73%), while in 2 (18%) patients localization was either to frontal lobe or parietooccipital region. Only one of 11 (9%) MRI scans revealed no abnormality. This has been performed 4 days after symptom onset. In this patient, examination of CSF (taken on day 5 from onset of symptoms) revealed positive PCR for HSV. Subacute hemorrhagic lesions, as revealed by high sign intensities on T1-MRI images, were detected in 2 patients. In a 6-month-old boy with HSE, the initial CT (done on day 5 after the onset of symptoms) showed bilateral hypodensity in the temporal lobes. Cranial MRI done 12 days later, showed the temporal lesions, as well as subacute hemorrhage at the pons (Fig. 1) . Both lesions showed remarkable resolution on a follow-up MRI done about 18 months later.
Seventeen (94%) of 18 children had EEG assessment, and abnormalities were present in all of them. These consisted of non-specific diffuse slow waves in 4 (24%) patients and focal slow waves in 13(76%). Slowing was restricted to the temporal area in 7(41%) while 6(35%) patients displayed typical PLEDs. However, there has been no significant association between the presence of PLEDs on EEG and a positive PCR result for HSV in the CSF (P = 0.64).
Fourteen (78%) of the 18 patients had a total of 18 SPECT brain scans. Of these scans, 14(78%) were during admission with acute HSE within a period ranging between 2 and 19 days after the onset of symptoms (mean [+SD] = 9.3 + 5.77 days, median = 7 days). The rest (12%) were done after the infection has resolved within a period ranging between 8 months and 3 years. Tc-DTPA showed increased uptake after the 7 th day from the onset of symptoms. The third radiopharmaceutical ( 99m Tc-EDC) was used in one patient with hemorrhagic HSE who had SPECT brain scan at 12 days from onset of symptoms. Of the 4 SPECT scans which were done within a period of < 7 days using 99m Tc-HMPAO, 3(75%) showed increased perfusion and the fourth revealed decreased perfusion. Likewise, using 99m Tc-DTPA three (75%) of the four SPECT scans showed evidence of BBB breakdown and increased uptake, whereas the fourth patient had decreased uptake. The 4 patients with evidence of BBB breakdown included a 10-month-old boy who had hemorrhagic HSE (Fig. 2) . Carotid angiography in this patient (done to rule out a suspected arteriovenous malformation) showed no evidence of vascular anomaly.
The clinical features and investigation results of the 3 children who had relapsing HSE are shown in Tables 2 and  3 . During the initial infection ( Table 2) , their ages were 2 years, 20 months and 4 years, respectively. Relapses occurred after periods ranging between 18 days and 66 months. None of them was immune-compromised. Neurological manifestations of the relapses (Table 3 ) were drowsiness, or decreased level of consciousness, and hemiparesis in two patients associated with abducent nerve palsy in one of them. Patient 2 ( Table 3) had choreoform movements two weeks after admission with relapse and starting acyclovir therapy. Patient 1 ( Table 2) , who had acyclovir for 10 days, relapsed 18 days after the initial HSE and presented with choreoform movements (Table 3) . In the three patients, relapse was best detected by MRI which showed sequelae of old infection and also signs of recent infection on diffusion-weighted images and/or T2-weighted images (Fig. 3) . Signs of inflammatory changes were in the same site of the disease in Patient 2 (Fig. 3) , while it extended to the contralateral side in the other two patients. Of note is that the relapse in Patient 2 was associated with lip vesicular lesions. A swab from these revealed positive immunofluorescence for HSV type 1 (Fig. 3) . It's also noteworthy that Patient 2 was admitted with his initial infection to KKUH 40 days after onset of symptoms ( Table  2) . He had interrupted acyclovir therapy at another 2 hospitals since his parents took him against medical advice looking for other medical opinions. Analysis of CSF on admission revealed negative results for HSV PCR. Four days after start of acyclovir, his fever relapsed again. Brain MRI (done 2 days later) showed bifrontal cystic encephalomalacia associated with diffused white matter attenuation (Fig. 3A) .
There were no deaths in this cohort of 18 patients, 10 (56%) had no sequelae of HSE, whereas one (6%) patient had minor sequelae in the form of minor neuropsychological deficits. Two (11%) patients had moderate sequelae in the form of easily controlled seizures or attention deficit hyperactivity disorder. Severe sequelae were seen in 5 (28%) patients. These consisted of residual cerebral palsy, intractable seizures and/or mental retardation requiring th Jan. 1995, shows small resolving low signal lesions at the pons (arrows) and (F) Axial T2-weighted MRI on the same date, shows smaller resolving high signal lesions at temporal lobes (arrows). supporting care. There was no statistically significant difference between the poor (moderate or severe sequelae) and good (minor or no sequelae) outcome groups with regards to the duration of therapy (< 14 days vs 21 days). However, the difference was highly significant regarding the initiation of acyclovir treatment, either early (< 3 days) or later (p = 0.002). All patients with good outcome received acyclovir within 3 days from the start of symptoms while 71% of patients with poor outcome received treatment late (with delays for up to 25 days).
DISCUSSION
The clinical spectrum of the disease in our patients was in accordance with that reported in the literature [3, 22] Fever (present in all cases), seizures (in 73%), disturbed sensorium (irritability and drowsiness), and focal neurologic features (hemiparesis, 6 th cranial nerve palsy and aphasia) were the main features. The lack of pathognomonic clinical presentation of HSE and similarities with those of encephalitis due to other viruses, metabolic encephalopathy (including mitochondrial disease) and stroke could explain the initial delayed diagnosis of some patients in the present cohort at their primary care centers [23, 24] .
Although typical laboratory results are highly suggestive of HSV (CSF pleocytosis, the presence of RBCs and elevated protein levels, the absence of these features does not rule out a diagnosis of HSE [9, 10] . In the present study, 8(38%) of the 21 CSF samples drawn between days 1 and 5 of illness showed < 10 WBC/μl. It's noteworthy that although CSF pleocytosis is usually present in about 97% of cases [17] , it may be absent in either immunocompetent [9, 25] or immunocompromised patients [26] . Also the presence of RBC, following a non-traumatic lumbar puncture, is encountered with similar frequency in patients with encephalitis due to other causes [17] .
Six (50%) cases had negative CSF PCR, despite other evidence suggestive of HSV infection, which conforms with previous reports that a single negative PCR result does not exclude HSV as a cause of acute encephalitis [3, 8, 9, 27] . Also, one patient showed negative results on day 3 but positive results on repeated CSF testing on day 8 of his illness. This also consolidates previous observations that initial negative PCR results obtained within the first 3 days of illness may become positive on a subsequent CSF specimen, and should not interrupt antiviral therapy [6, 8, 10, 16, 27] . False negative results could be due to the absence of HSV or the presence of a very low viral load in the CSF at the onset acute encephalitis in children [6, 8, 10] . Other causes of false-negative HSV PCR results include the presence of porphyrin compounds in CSF derived from the degradation of haeme in erythrocytes [28] . Hence, caution should be used in interpreting negative PCR results in bloody CSF specimens. In the present study, neuroimaging had significant impact as diagnostic tools. Cranial CT Scan was done for 14 patients, while 11 patients were evaluated with MRI. But because our patients did only CT, only MRI, neither or both at different times of the disease course, we were unable to compare the sensitivity of these modalities for diagnosis. However, initial CT scans done on days 1-8 from onset of symptoms were normal in 5 (50%) of 10 patients, compared to one (9%) of eleven MRI scans done during the acute stage. Our results are in agreement with other studies which confirmed the superiority of MRI, as neuro-imaging modality, for detecting lesions of HSE [8, 10, 29] . In the present study abnormalities were mainly confined to the temporal lobes (73%) but could also be seen in other regions, similar the experiences of others [8, 10] . Extra temporal (including cortical and subcortical) regions are detected in 40% of children but only in 9-15% of adult patients [3] . On the other hand, diffuse white matter involvement was seen in a child (Patient 2, Table 2 ; Fig. 3A ) who developed choreoathetoid movements while he was on antiviral therapy. Such evolution of HSE has been well described [30] , and is considered to be due to the occurrence of post infectious immune-mediated encephalitis [3, 27, 31] . Also in agreement with previous studies indicating that HSE in children and adults is commonly hemorrhagic [31] [32] [33] , we found hyperdense lesions of hemorrhage in 60% of cranial CT scans of our patients. In the present study, all patients showed abnormalities on EEG tracings and 6 (35%) displayed PLEDs. In a recent study by Elbers and associates [10] , PLEDs were found in 2(13%) patients whereas an earlier study on adult HSE showed that these periodic complexes had sensitivity of 81% and specificity of 59% [17] . Although PLEDs are seen in other cerebral disorders [34, 35] , their presence in the setting of a rapidly progressive neurological disease associated with fever is strongly indicative of HSV-1 encephalitis [22] .
Although treatment with acyclovir significantly improves the outcome of HSE, the reported mortality rate in patients treated with acyclovir ranged between 0% and 10% in children compared to nearly 20% in adults [3, [36] [37] [38] . There were no deaths in our cohort but 5 (28%) patients experienced severe neurologic sequelae in the form of intractable seizures, mental retardation and/or residual cerebral palsy; and 3 patients relapsed. Two (11%) patients had moderate sequelae consisting of easily controlled seizures or ADHD. In earlier reports the rates of moderate sequelae ranged from 25% to 36% and of severe neurological disabilities from 0 to 100% [37, 39] , compared to 30%-31% and 5% to 31%, respectively, in the more recent studies [10, 40] . These varied proportions reflect differences in evaluation criteria and duration of follow-up.
Similar to the experiences of others [40, 41] , no significant difference was noted in the outcome with the different durations of treatment given. Patients who recover without sequelae of HSE, even with no antiviral therapy, have been reported [41] and they are thought to constitute the group of patients who are only mildly infected [40] . However, in two studies [36, 42] , the duration of treatment and total dosage of acyclovir given were significantly less in children with early HSE relapse than in the non-recurrent group. Conversely, all eleven patients with good outcome in the present study received acyclovir within 3 days from start of symptoms while 5(71%) of the 7 patients with poor outcome were delayed in diagnosis and treatment (P = 0.002). Delayed initiation of acyclovir therapy is a known poor prognostic factor [40, 43] . Hence, since in the early beginnings of illness the outcome of patients with HSE cannot be predicted, and because of the disastrous effects of delayed treatment, early diagnosis and proper acyclovir initiation are vital for proper management [3, 22, 27, 40] .
In children, recurrence or relapse of HSE occurs in 5-26% of acyclovir -treated patients [9, 42] . The pathogenesis of this condition is poorly defined, but persistent herpes simplex virus replication, reactivation, or immune-mediated mechanisms may play a role [3, 44] . The CSF may be negative for HSV by PCR [44] . However, the presence of a positive CSF PCR, as seen in Patient 2 ( Table 3 ), suggests that relapse is due to persistent viral infection rather than a post-infections immune-mediated process [27] . Patient 1 ( Table 2 ) in the present study, who experienced a relapse 18 days after first HSE episode, has been treated initially with a 10-day course of acyclovir. This may conform to previous observations that a 21-day course of acyclovir is more effective in reducing the risk of recurrence associated with HSE [3, 10, 30] . It's noteworthy that in the past decade, the standard care became an increase in the duration of treatment from 14 days to 21 days [45] . However, the other two relapsing children (patients 2 and 3, Table 2 ) had the full 21-day course of acyclovir during their initial admissions to KKUH. They relapsed after periods of 66 months and 22 months, respectively. Patient 3 ( Table 2 ) had her sister afflicted with HSE and is enrolled in the present study. Taken together, these observations may point to an underlying genetic susceptibility. Several studies have appeared recently unraveling the genetic basis of HSE [46] [47] [48] . They proved that, at least in some of children, HSE results from a series of autosomal recessively (AR) inherited monogenic primary immunodeficiencies that impair the TLR3-and UNC-93B-dependent-production of interferon (INF) [Alpha/beta] and IFN (lambda) in the central nervous system. Given the impact of AR inheritance in the pathogenesis of pediatric neurologic diseases in this region [49] , studies are underway to investigate, in a collaborative research, this genetic susceptibility in our cohort of patients, as well as, in children admitted with HSE after the present study period.
